StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report released on Thursday morning. The brokerage issued a buy rating on the stock.
Mannatech Price Performance
NASDAQ MTEX opened at $8.05 on Thursday. The company has a market cap of $15.17 million, a PE ratio of -9.04 and a beta of 1.17. Mannatech has a 52 week low of $6.75 and a 52 week high of $10.51. The company has a quick ratio of 0.62, a current ratio of 1.17 and a debt-to-equity ratio of 0.54. The firm’s 50-day simple moving average is $7.54 and its two-hundred day simple moving average is $7.60.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) EPS for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The business had revenue of $27.74 million for the quarter.
Insider Activity
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- What is MarketRank™? How to Use it
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- What Does Downgrade Mean in Investing?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Most Volatile Stocks, What Investors Need to Know
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.